Storchova Zuzana, Kuffer Christian
Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.
J Cell Sci. 2008 Dec 1;121(Pt 23):3859-66. doi: 10.1242/jcs.039537.
Polyploidy, an increased number of chromosome sets, is a surprisingly common phenomenon in nature, particularly in plants and fungi. In humans, polyploidy often occurs in specific tissues as part of terminal differentiation. Changes in ploidy can also result from pathophysiological events that are caused by viral-induced cell fusion or erroneous cell division. Tetraploidization can initiate chromosomal instability (CIN), probably owing to supernumerary centrosomes and the doubled chromosome mass. CIN, in turn, might persist or soon give way to a stably propagating but aneuploid karyotype. Both CIN and stable aneuploidy are commonly observed in cancers. Recently, it has been proposed that an increased number of chromosome sets can promote cell transformation and give rise to an aneuploid tumor. Here, we review how tetraploidy can occur and describe the cellular responses to increased ploidy. Furthermore, we discuss how the specific physiological changes that are triggered by polyploidization might be used as novel targets for cancer therapy.
多倍体,即染色体组数量增加,是自然界中一种惊人的常见现象,尤其是在植物和真菌中。在人类中,多倍体常作为终末分化的一部分出现在特定组织中。倍性变化也可能由病毒诱导的细胞融合或错误的细胞分裂等病理生理事件引起。四倍体化可引发染色体不稳定性(CIN),这可能是由于多余的中心体和加倍的染色体质量所致。反过来,CIN可能持续存在,或者很快让位于稳定增殖但非整倍体的核型。CIN和稳定的非整倍体在癌症中都很常见。最近,有人提出染色体组数量增加可促进细胞转化并导致非整倍体肿瘤的产生。在此,我们综述四倍体如何发生,并描述细胞对倍性增加的反应。此外,我们讨论多倍体化引发的特定生理变化如何可作为癌症治疗的新靶点。